Alectinib | CAS No. 1256580-46-7

Alectinib

Basic Information

View in Editor

CAS Number

1256580-46-7

Molecular Formula

C30H34N4O2

Molecular Weight

482.62 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Nitriles

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

SMILES

View in Editor

CCc1cc2C(=O)c3c([nH]c4cc(C#N)ccc34)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6

InChI

InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3

InChIKey

KDGFLJKFZUIJMX-UHFFFAOYSA-N

LogP

4.77618

Complexity

867

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

CH 5424802
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile
9-ethyl-6,6-dimethyl-8-(4-morpholinopiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
Alectinib
Alectinib (CH5424802)
9-ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-5h-benzo(b)carbazole-3-carbonitrile
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
AF802
AF-802
CH-5424802
UNII-LIJ4CT1Z3Y
9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile
CH 5424802,Alectinib
CH5424802
Alecensa
RO5424802
Alectinib free base
AF 802
LIJ4CT1Z3Y

MDL Number

MFCD19440988

FAQ

What regulatory guidelines apply to Alectinib (CAS: 1256580-46-7)?

Alectinib (CAS: 1256580-46-7) is regulated under the REACH regulations in the European Union, which requires manufacturers and importers to register substances if they exceed the tonnage threshold. In the USA, the FDA may require specific regulatory submissions and approvals. Additionally, it is subject to GHS classification for hazardous properties and may be regulated by the EPA for environmental and safety standards.

Are there alternatives to Alectinib (CAS: 1256580-46-7) in synthesis?

Alternatives to Alectinib include other anaplastic lymphoma kinase (ALK) inhibitors such as crizotinib and ceritinib. These compounds may be used in the synthesis of Alectinib as they share similar mechanisms of action. Other synthetic strategies may involve using isomers or analogs that offer improved efficacy or reduced side effects.

What is the market or research trend for Alectinib (CAS: 1256580-46-7)?

The market for Alectinib is growing due to its efficacy in treating ALK-positive non-small cell lung cancer. Research trends focus on its use in combination therapies and its potential in treating other cancers. Market trends also reflect increasing demand for precision oncology treatments.

How should waste containing Alectinib (CAS: 1256580-46-7) be handled?

Waste containing Alectinib should be collected in suitable containers and stored in a secure, well-ventilated area until disposal. It should be incinerated or disposed of through a professional waste disposal service that follows environmental protection standards. Proper labeling and documentation are essential to comply with regulatory requirements and ensure safety during disposal.